Word mark

Trademark: 'FTORAL' 
Teva Pharmaceutical Industries Ltd.
European Community Trademark, no. 000115519, Word mark

 

On 1. 4. 1996 the community trademark application no. 000115519 was filed for FTORAL (Word mark) by Teva Pharmaceutical Industries Ltd. before the OAMI.The goods and services in respect of which registration of the trademark was sought are in class 5. The current status of the trademark is application withdrawn.

Status is 'Application withdrawn'
The Community Trade Mark application has been withdrawn by the applicant for whatever reason. So right now there is no protection of this very trademark ad you can file it.

Applied1. 4. 1996
Nice classes5

 
 

You can follow this trademark. You will receive an email, whenever we detect changes of the trademark filing.
This service is for free. You can unsubsribve whenever you want. More information.

 

Owner

Teva Pharmaceutical Industries Ltd.
Science Based Industries Campus, Har Hotzvim, P.O. Box 1142
91010 Jerusalem
IL

 

If you are the trademark owner and the data above are not correct, then please update them soon by clicking on Update address.

If you want to transfer the trademark to another owner, click on Transfer trademark.

You can transfer a trademark partially or completely to another owner. A partial transfer means that you can transfer a trademark in specific classes.

Still questions? Call us : 0049 (0) 89 6666 10 89

Representative

LADAS & PARRY LLP
Temple Chambers, 3-7 Temple Avenue
EC4Y 0DA London
GB

 

If the data above is not correct, then please choose Update.

 
 

Nice classes

5  Pharmaceutical preparations and substances.

 
 
 

Records history

 
8.12.2016 The current state is Application withdrawn
Current state
13.10.2008 Published
Representative - Change of name and professional address
20.8.2007 Published
Representative - Change of name and professional address
1.4.1996 Application
Application of the trademark 000115519 FTORAL
 

Further trademarks of the owner

TEVA
GRY TEVA GROUP
theTEVA WAY
TEVA NEUROSCIENCE
abstract MEDICAL REVIEW
TEVA-TECH